SCYNEXIS, Inc. Proceeds from Sales of Assets, Investing Activities
SCYNEXIS, Inc. (SCYX) reported Proceeds from Sales of Assets, Investing Activities of $0 for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-07.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSalesOfAssetsInvestingActivities · last filed 2018-03-13
- SCYNEXIS, Inc. proceeds from sales of assets, investing activities for the quarter ending 2016-12-31 was $0.00.
- SCYNEXIS, Inc. proceeds from sales of assets, investing activities for the quarter ending 2015-12-31 was $0.00.
- SCYNEXIS, Inc. proceeds from sales of assets, investing activities for the quarter ending 2014-12-31 was $0.00.
- SCYNEXIS, Inc. proceeds from sales of assets, investing activities for the quarter ending 2014-09-30 was $0.00, a 100.00% decline year-over-year.
- SCYNEXIS, Inc. proceeds from sales of assets, investing activities for fiscal 2016 was $500.00K, a 80.38% decline from fiscal 2015.
- SCYNEXIS, Inc. proceeds from sales of assets, investing activities for fiscal 2015 was $2.55M.
- SCYNEXIS, Inc. proceeds from sales of assets, investing activities for fiscal 2014 was $0.00.
| Period end | Proceeds from Sales of Assets, Investing Activities 3 month | Proceeds from Sales of Assets, Investing Activities 6 month | Proceeds from Sales of Assets, Investing Activities 9 month | Proceeds from Sales of Assets, Investing Activities 12 month |
|---|---|---|---|---|
| 2017-09-30 | $0.00 10-Q · filed 2017-11-07 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $500.00K 10-K · filed 2018-03-13 | ||
| 2016-09-30 | $500.00K 10-Q · filed 2017-11-07 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $2.55M 10-K · filed 2017-03-13 | ||
| 2015-09-30 | $2.55M 10-Q · filed 2015-11-13 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $0.00 derived: sum of 2 quarters · filed 2017-03-13 | $0.00 10-K · filed 2017-03-13 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $0.00 10-Q · filed 2015-11-13 | ||
| 2014-06-30 | $0.00 10-Q · filed 2014-08-13 | |||
| 2013-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2015-10-30 | $2.00K derived: sum of 2 quarters · filed 2015-10-30 | $474.00K derived: sum of 3 quarters · filed 2015-10-30 | $988.00K 8-K · filed 2015-10-30 |
| 2013-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $474.00K derived: sum of 2 quarters · filed 2014-11-13 | $988.00K 10-Q · filed 2014-11-13 | |
| 2013-06-30 | $472.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2014-08-13 | $986.00K 10-Q · filed 2014-08-13 | ||
| 2013-03-31 | $514.00K 10-Q/A · filed 2014-07-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |